Overview
Hip dysplasia, Beukes type (also known as Beukes familial hip dysplasia or coxarthrosis) is a rare inherited skeletal disorder first described in a large Afrikaner family in South Africa. The condition primarily affects the hip joints, leading to progressive premature degenerative arthritis (osteoarthritis) of the hips. It is caused by a pathogenic variant in the UFSP2 gene on chromosome 4q35, which encodes a protease involved in the UFM1 ubiquitin-like modification pathway. The disease typically manifests in early childhood, with affected individuals developing hip dysplasia characterized by flattening and irregularity of the femoral heads (the ball portion of the hip joint). Over time, this leads to progressive joint degeneration, pain, and significant limitation of hip mobility. The condition appears to be largely confined to the hip joints, distinguishing it from more generalized skeletal dysplasias, although mild changes in other joints have occasionally been noted. Radiographic findings include fragmentation and flattening of the femoral capital epiphyses, resembling Legg-Calvé-Perthes disease, but occurring bilaterally and with a clear hereditary pattern. There is currently no cure or disease-specific treatment for Beukes type hip dysplasia. Management is symptomatic and supportive, focusing on pain relief, physical therapy to maintain mobility, and orthopedic interventions. Many affected individuals ultimately require total hip replacement surgery due to severe degenerative changes. Genetic counseling is recommended for affected families given the autosomal dominant inheritance pattern.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Hip dysplasia, Beukes type.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hip dysplasia, Beukes type at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Hip dysplasia, Beukes type.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hip dysplasia, Beukes type.
Community
No community posts yet. Be the first to share your experience with Hip dysplasia, Beukes type.
Start the conversation →Latest news about Hip dysplasia, Beukes type
No recent news articles for Hip dysplasia, Beukes type.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hip dysplasia, Beukes type
What is Hip dysplasia, Beukes type?
Hip dysplasia, Beukes type (also known as Beukes familial hip dysplasia or coxarthrosis) is a rare inherited skeletal disorder first described in a large Afrikaner family in South Africa. The condition primarily affects the hip joints, leading to progressive premature degenerative arthritis (osteoarthritis) of the hips. It is caused by a pathogenic variant in the UFSP2 gene on chromosome 4q35, which encodes a protease involved in the UFM1 ubiquitin-like modification pathway. The disease typically manifests in early childhood, with affected individuals developing hip dysplasia characterized by
How is Hip dysplasia, Beukes type inherited?
Hip dysplasia, Beukes type follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Hip dysplasia, Beukes type typically begin?
Typical onset of Hip dysplasia, Beukes type is childhood. Age of onset can vary across affected individuals.